DrugDashboards

Market view

crisaborole · Powder

12 marketed package NDCs · 11 active manufacturers

Most dispensed: 20 mg/g · Ointment · #1 tube/carton / 60 g in 1 tube · 20 mg/g · Ointment · #1 tube/carton / 100 g in 1 tube

The short version

11 companies supply this market — deep enough that no single failure threatens the supply.

What changed in the last 90 days

Every detected change for crisaborole, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • EucrisaAug 19, 2026
    Price down
    NADAC $12.64778 → $12.64608 per unit (-0.01%)
  • EucrisaAug 19, 2026
    Price up
    NADAC $10.68596 → $10.69056 per unit (+0.04%)
  • EucrisaJul 22, 2026
    Price up
    NADAC $10.68507 → $10.68596 per unit (+0.01%)
  • EucrisaJul 22, 2026
    Price down
    NADAC $12.64937 → $12.64778 per unit (-0.01%)

Same drug class

Other molecules FDA puts in Phosphodiesterase 4 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Crisaborole in shortage right now?
No. FDA does not currently list Crisaborole in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Crisaborole?
13 companies have marketed Crisaborole in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Crisaborole cost?
The typical pharmacy pays about $11.67 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.